News

“Liquid ecstasy” trading to be investigated

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7165.1035a (Published 17 October 1998) Cite this as: BMJ 1998;317:1035
  1. Alex Brooks
  1. BMJ

    Investigations into the illegal trading and advertising of gammahydroxybutyrate have been stepped up by the Medicines Control Agency. The drug is not licensed in the United Kingdom and can be prescribed only by a doctor on a named patient basis.

    The drug, also known as liquid ecstasy, has been promoted for body builders--who believe it stimulates the body's …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe